A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment cheaper for thousands of Australians.

A new study published in Psychoneuroendocrinologysheds light on the complex relationship between postnatal depression and ...

When oxytocin is inhaled via a nasal spray, it increases breast milk oxytocin levels, but it has less of an effect in new ...

This is when a patient has tried multiple forms of treatment for major depression—usually at ... The drug is provided as a single-use nasal spray. This application means it's absorbed directly ...

Spravato (esketamine) is a prescription drug that’s approved to treat certain forms of depression. Esketamine comes as a nasal spray that you inhale. Specifically, Spravato is approved by the ...

It is the first new medicine to treat depression funded by the Australian government in over 30 years. Image: iStock Esketamine nasal spray will soon be subsidised under the Pharmaceutical ...

Nevada Mental Health, one of the state’s largest psychiatric practices, just started offering SPRAVATO®, a nasal mist ...

You’ve taken the pills. You’ve journaled. You’ve done therapy, yoga, and even tried giving up caffeine and doom-scrolling ...

The drug is provided as a single-use nasal spray . This application means ... need to have been diagnosed with treatment-resistant depression . In practice, this means they will have ...

Postnatal depression occurs in approximately 20% ... All mothers were invited to use a nasal spray prior to breastfeeding which contained either the oxytocin hormone or a placebo.

This is when a patient has tried multiple forms of treatment for major depression – usually at ... The drug is provided as a single-use nasal spray. This application means it’s absorbed ...